Project Number 3P01AG002219-28S1 Agency/Funding Organization NIA Funding Year 2009 View Full Project Details for CLINICAL AND BIOLOGICAL STUDIES OF EARLY AD Research Categorization Primary Disease / Condition Alzheimer's Disease Vascular Dementia/Dysfunction CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 7. Multimodal Biomarkers Researcher and Organization Principal Investigator HAROUTUNIAN, VAHRAM Principal Investigator First Name VAHRAM Principal Investigator Last Name HAROUTUNIAN Awardee Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Awardee State New York, N.Y. Contact PI Country United States Project Detail FY Overall Cost $400,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) [AlzPED] Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.
